<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39365802</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Cost-effectiveness of SARS-CoV-2 self-testing at routine gatherings to minimize community-level infections in lower-middle income countries: A mathematical modeling study.</ArticleTitle><Pagination><StartPage>e0311198</StartPage><MedlinePgn>e0311198</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311198</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311198</ELocationID><Abstract><AbstractText>Places of worship serve as a venue for both mass and routine gathering around the world, and therefore are associated with risk of large-scale SARS-CoV-2 transmission. However, such routine gatherings also offer an opportunity to distribute self-tests to members of the community to potentially help mitigate transmission and reduce broader community spread of SARS-CoV-2. Over the past four years, self-testing strategies have been an impactful tool for countries' response to the COVID-19 pandemic, especially early on to mitigate the spread when vaccination and treatment options were limited. We used an agent-based mathematical model to estimate the impact of various strategies of symptomatic and asymptomatic self-testing for a fixed percentage of weekly routine gatherings at places of worship on community transmission of SARS-CoV-2 in Brazil, Georgia, and Zambia. Testing strategies assessed included weekly and bi-weekly self-testing across varying levels of vaccine effectiveness, vaccine coverage, and reproductive numbers to simulate developing stages of the COVID-19 pandemic. Self-testing symptomatic people attending routine gatherings can cost-effectively reduce the spread of SARS-CoV-2 within places of worship and the community, resulting in incremental cost-effectiveness ratios of $69-$303 USD. This trend is especially true in contexts where population level attendance at such gatherings is high, demonstrating that a distribution approach is more impactful when a greater proportion of the population is reached. Asymptomatic self-testing of attendees at 100% of places of worship in a country results in the greatest percent of infections averted and is consistently cost-effective but remains costly. Budgetary needs for asymptomatic testing are expensive and likely unaffordable for lower-middle income countries (520-1550x greater than that of symptomatic testing alone), promoting that strategies to strengthen symptomatic testing should remain a higher priority.</AbstractText><CopyrightInformation>Copyright: © 2024 Hansen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Megan A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0009-0007-0003-7179</Identifier><AffiliationInfo><Affiliation>Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Alvin X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Joshua M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klock</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandithakoralage</LastName><ForeName>Hiromi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nooy</LastName><ForeName>Alexandra de</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ockhuisen</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girdwood</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FIND, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lekodeba</LastName><ForeName>Nkgomeleng A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Shaukat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>FIND, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Helen E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Cheryl C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO), Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacks</LastName><ForeName>Jilian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO), Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Colin A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Brooke E</ForeName><Initials>BE</Initials><Identifier Source="ORCID">0000-0003-4682-4999</Identifier><AffiliationInfo><Affiliation>Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FIND, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="Y">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085263" MajorTopicYN="Y">Self-Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015024" MajorTopicYN="N" Type="Geographic">Zambia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090522" MajorTopicYN="N">Mass Gatherings</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. The views expressed in this manuscript are those of the authors and do not necessarily represent the official position of the WHO.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365802</ArticleId><ArticleId IdType="pmc">PMC11451991</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311198</ArticleId><ArticleId IdType="pii">PONE-D-23-40614</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [Internet]. [cited 2024 Jun 28]. Available from: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</Citation></Reference><Reference><Citation>COVID-19 cases | WHO COVID-19 dashboard [Internet]. [cited 2024 Jun 28]. Available from: https://data.who.int/dashboards/covid19/cases</Citation></Reference><Reference><Citation>FIND COVID-19 Test tracker [Internet]. [cited 2024 Jun 28]. Available from: https://www.finddx.org/tools-and-resources/dxconnect/test-directories/covid-19-test-tracker/</Citation></Reference><Reference><Citation>WHO issues its first emergency use listing for a SARS-CoV-2 self-test | WHO—Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control) [Internet]. [cited 2024 Jun 28]. Available from: https://extranet.who.int/prequal/news/who-issues-its-first-emergency-use-listing-sars-cov-2-self-test</Citation></Reference><Reference><Citation>Jamieson L, Johnson LF, Matsimela K, Sande LA, d’Elbée M, Majam M, et al.. The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis. BMJ Global Health. 2021. Jul 1;6(Suppl 4):e005598. doi: 10.1136/bmjgh-2021-005598</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005598</ArticleId><ArticleId IdType="pmc">PMC8287627</ArticleId><ArticleId IdType="pubmed">34275876</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker JG, Easterbrook P, Fajardo E, Ivanova E, Jamil MS, Johnson C, et al.. Cost-effectiveness of hepatitis C virus self-testing. In: Recommendations and guidance on hepatitis C virus self-testing [Internet]. World Health Organization; 2021.  [cited 2024 Jun 28]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572736/</Citation></Reference><Reference><Citation>Key planning recommendations for mass gatherings in the context of COVID-19 [Internet]. [cited 2024 Jun 28]. Available from: https://www.who.int/publications/i/item/10665-332235</Citation></Reference><Reference><Citation>Yasutaka T, Murakami M, Iwasaki Y, Naito W, Onishi M, Fujita T, et al.. Assessment of COVID-19 risk and prevention effectiveness among spectators of mass gathering events. Microbial Risk Analysis. 2022. Aug 1;21:100215. doi: 10.1016/j.mran.2022.100215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mran.2022.100215</ArticleId><ArticleId IdType="pmc">PMC8969296</ArticleId><ArticleId IdType="pubmed">35382415</ArticleId></ArticleIdList></Reference><Reference><Citation>Revollo B, Blanco I, Soler P, Toro J, Izquierdo-Useros N, Puig J, et al.. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. The Lancet Infectious Diseases. 2021. Oct 1;21(10):1365–72. doi: 10.1016/S1473-3099(21)00268-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00268-1</ArticleId><ArticleId IdType="pmc">PMC8457773</ArticleId><ArticleId IdType="pubmed">34051886</ArticleId></ArticleIdList></Reference><Reference><Citation>Estelle CD, Perl TM. To Test or Not to Test: COVID-19 Prevention Strategies to Keep Large Gatherings Safe. Ann Intern Med. 2021. Oct 19;174(10):1470–1. doi: 10.7326/M21-2976</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-2976</ArticleId><ArticleId IdType="pmc">PMC8296719</ArticleId><ArticleId IdType="pubmed">34280334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang VT, Gautret P, Memish ZA, Al-Tawfiq JA. Hajj and Umrah Mass Gatherings and COVID-19 Infection. Curr Trop Med Rep. 2020. Nov 3;7(4):133–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7609349</ArticleId><ArticleId IdType="pubmed">33169095</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AX, Girdwood SJ, Khan S, Sacks JA, Toporowski A, Huq N, et al.. Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia. Clinical Infectious Diseases. 2023. Feb 15;76(4):620–30. doi: 10.1093/cid/ciac814</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac814</ArticleId><ArticleId IdType="pmc">PMC9619661</ArticleId><ArticleId IdType="pubmed">36208211</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AX, Hannay E, Carmona S, Rodriguez B, Nichols BE, Russell CA. Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs. Nat Commun. 2023. Dec 2;14(1):7981. doi: 10.1038/s41467-023-43769-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43769-z</ArticleId><ArticleId IdType="pmc">PMC10693634</ArticleId><ArticleId IdType="pubmed">38042923</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AX, Toporowski A, Sacks JA, Perkins MD, Briand S, van Kerkhove M, et al.. SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs. Nat Genet. 2023. Jan 9;55(1):26–33. doi: 10.1038/s41588-022-01267-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01267-w</ArticleId><ArticleId IdType="pmc">PMC9839449</ArticleId><ArticleId IdType="pubmed">36624344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambia Statistics Agency–Quality Statistics for Development [Internet]. 2024 [cited 2024 Jul 16]. Available from: https://www.zamstats.gov.zm/</Citation></Reference><Reference><Citation>Brazilian Institute of Geography and Statistics, IBGE–Censo 2010 [Internet]. [cited 2024 Jul 16]. Available from: https://censo2010.ibge.gov.br/</Citation></Reference><Reference><Citation>National Statistics Office of Georgia–Census, 2014 –მთავარი [Internet]. [cited 2024 Jul 17]. Available from: https://www.geostat.ge/en</Citation></Reference><Reference><Citation>The Age Gap in Religion Around the World [Internet]. Pew Research Center. 2018 [cited 2024 Jul 16]. Available from: https://www.pewresearch.org/religion/2018/06/13/the-age-gap-in-religion-around-the-world/</Citation></Reference><Reference><Citation>NDI time-series dataset Georgia [Internet]. Caucas Research Resource Center. 2020 [cited 2024 Jul 16]. Available from: https://www.caucasusbarometer.org/en/ndi-ge/RELSERV/</Citation></Reference><Reference><Citation>Report on International Religious Freedom: Zambia [Internet]. United States Department of State. [cited 2024 Jul 16]. Available from: https://www.state.gov/reports/2020-report-on-international-religious-freedom/zambia/</Citation></Reference><Reference><Citation>Support Package including US $7 million investment accelerates availability of affordable COVID-19 self-tests in low- and middle-income countries [Internet]. FIND. [cited 2024 Jul 16]. Available from: https://www.finddx.org/publications-and-statements/support-package-including-us7-million-investment-accelerates-availability-of-affordable-covid-19-self-tests-in-low-and-middle-income-countries/</Citation></Reference><Reference><Citation>Hansen MA, Lekodeba NA, Chevalier JM, Ockhuisen T, Rey-Puech P del, Marban-Castro E, et al.. Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines). BMJ Open. 2024. Apr 1;14(4):e078852. doi: 10.1136/bmjopen-2023-078852</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-078852</ArticleId><ArticleId IdType="pmc">PMC11029185</ArticleId><ArticleId IdType="pubmed">38631825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sande LA, Matsimela K, Mwenge L, Mangenah C, Choko AT, d’Elbée M, et al.. Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe. BMJ Global Health. 2021. Jul 1;6(Suppl 4):e005191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287606</ArticleId><ArticleId IdType="pubmed">34275874</ArticleId></ArticleIdList></Reference><Reference><Citation>Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al.. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value Health. 2022. Jan;25(1):10–31. doi: 10.1016/j.jval.2021.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2021.10.008</ArticleId><ArticleId IdType="pubmed">35031088</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Results Briefing: Brazil [Internet]. Institute for Health Metrics and Evaluation, IHME. [cited October 13, 2022]. Available from: https://www.healthdata.org/research-analysis/diseases-injuries/covid/policy-briefings</Citation></Reference><Reference><Citation>COVID-19 Results Briefing: Georgia [Internet]. Institute for Health Metrics and Evaluation, IHME. [cited October 13, 2022]. Available from: https://www.healthdata.org/research-analysis/diseases-injuries/covid/policy-briefings</Citation></Reference><Reference><Citation>COVID-19 Results Briefing: Zambia [Internet]. Institute for Health Metrics and Evaluation, IHME. [cited October 13, 2022]. Available from: https://www.healthdata.org/research-analysis/diseases-injuries/covid/policy-briefings</Citation></Reference><Reference><Citation>González López-Valcárcel B, Vallejo-Torres L. The costs of COVID-19 and the cost-effectiveness of testing. Applied Economic Analysis. 2021. Jan 1;29(85):77–89.</Citation></Reference><Reference><Citation>Chevalier JM, Han AX, Hansen MA, Klock E, Pandithakoralage H, Ockhuisen T, et al.. Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis. BMJ Open. 2024. Feb 1;14(2):e078674. doi: 10.1136/bmjopen-2023-078674</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-078674</ArticleId><ArticleId IdType="pmc">PMC10900377</ArticleId><ArticleId IdType="pubmed">38417953</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz NA, Othman J, Lugova H, Suleiman A. Malaysia’s approach in handling COVID-19 onslaught: Report on the Movement Control Order (MCO) and targeted screening to reduce community infection rate and impact on public health and economy. Journal of Infection and Public Health. 2020. Dec 1;13(12):1823–9. doi: 10.1016/j.jiph.2020.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.08.007</ArticleId><ArticleId IdType="pmc">PMC7456294</ArticleId><ArticleId IdType="pubmed">32896496</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadri SA. COVID-19 and religious congregations: Implications for spread of novel pathogens. International Journal of Infectious Diseases. 2020. Jul 1;96:219–21. doi: 10.1016/j.ijid.2020.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7204705</ArticleId><ArticleId IdType="pubmed">32389851</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>